Loading...
Alan M. Nieder Application PackageCITY OF MIAMI BEACH BOARD AND COMMITTEE APPLICATION FORM NIEDERALANM NAME: First Name Last Name Middle Initial FL33141 HOME ADDRESS : 6340 PINETREE DRMIAMI BEACH Home No./StreetState Apt No.City Zip Code anieder@msmc.com 3056742499305-674-2499 PHONE : WorkEmail Address Home PHYSICIAN Business Name: MSMC DEPARTMENT OF UROLOGY Position: 4302 ALTON ROAD #540 MIAMI BEACHFL33140 Address: State CityZip Code Street Pursuant to City Code section 2-22(4) a and b: Members of agencies, boards, and committees shall be affiliated requirement shall be fulfilled in the following ways: a) an indi   months; or b) an individual shall demonstrate ownership/interest Yes Yes Yes circle one): I am now a resident of: Middle Beach I am Chairman of the Department of Urology at Mount Sinai Medica No 123Please note that only three (3) Please list your preferences in order of ranking [] first choice [] second choice, and [] third choice. choices will be observed by the City Clerk’s Office. (Regular Boards of City) Choice 1:Health Advisory Committee Choice 2:Health Facilities Authority Board Choice 3: Police/Citizens Relations Committee Note: If applying for Youth Advisory Board, please indicate your aff 1. Past service on the Youth Center Advisory Board: No Years of Service: if yes, please list the names of your children, their No 2. Present participation in Youth Center activities by your chil ages, and which programs. List below: No Have you ever been convicted of a felony:If yes, please explain in detail: Do you currently have a violation(s) of City of Miami Beach code No If yes, please explain in detail: Do you currently owe the City of Miami Beach any money:No If yes, please explain in detail: No Are you currently serving on any City Boards or Committees:If yes, which board? What organizations in the City of Miami Beach do you currently h List all properties owned or have an interest in, which are loca I am now employed by the city of Miami Beach:No Which department? The following information is voluntary and is neither part of yo being asked to comply with federal equal opportunity reporting r Gender:none Race/Ethnic Categories What is your race? Mark one or more races to indicate what you consider yourself t none Other Description: Are you Spanish/Hispanic/ Latino? Mark the "No" box if not Spani No No Physically Challenged: NOTEIf appointed, you will be required to follow certain laws which :   These laws include, but are not limited to, the following:    Prohibition from directly or indirectly lobbying city personnel o    Prohibition from contracting with the city (Miami-Dade County Co o    Prohibition from lobbying before board/committee you have served o Beach Code section 2-26).    Requirement to disclose certain financial interests and gifts (M o (re: CMB Community Development Advisory Committee):  prohibiti from having   any interest in or receiving any benefit from Co or those with whom you have business or immediate family ties Upon request, copies of these laws may be obtained from the “I hereby attest to the accuracy and truthfulness of the applica VII – of the City Code “Standards of Conduct for City Officers, I ALAN NIEDER agreed to the following terms on 11/21/2015 6:11:5 Received in the City Clerk's Office by: Name of Deputy Clerk Control No.Date Columbia University Curriculum Vitae 1.Date of preparation of C.V. September 28, 2015 2. Personal Data: Name: Alan M. Nieder, M.D. Citizenship: U.S.A. 3. Education: B.A. University of Michigan Ann Arbor, MI 1993 M.D. New York University School of Medicine New York, NY 1997 Alan M. Nieder, M.D. 2 4. Post-Doctoral Training (Residency & Fellowships): Resident, General Surgery New York University Medical Center New York, NY July 1997 à June 1999 Resident, Urology New York University Medical Center New York, NY July 1999 à June 2002 Chief Resident, Urology New York University Medical Center New York, NY July 2002 à June 2003 Fellow, Urologic Oncology University of Miami Medical Center Miami, FL Sept 2003 à Aug 2004 5. M.D. Licensure: Medical Licensure: New York State Medical License #211423 (1998) Florida State Medical License #ME87085 (2003) Drug Enforcement Agency License #BN8655891 (2004) Board Certification: Diplomat, American Board of Urology (2007) 6. Military Experience: N.A. Alan M. Nieder, M.D. 3 7. Professional Organizations and Societies American Urologic Association, 1998-date American Urologic Association, New York Section, 2004-2005 American Urologic Association, Southeast Section, 2005-date Florida Urological Society, 2006-date Society of Urologic Oncology, 2010-date Florida Urological Society, Alternative representative to the SESAUA Board of Directors, 2011-2012 Society of University Urologists, 2012-date Florida Urological Society, Representative to the SESAUA Board of Directors, 2012-2015 Alan M. Nieder, M.D. 4 8. Academic Appointments: Assistant Professor of Clinical Urology State University of New York (SUNY), at Stony Brook Department of Urology Stony Brook, NY September 2004 à May 2005 Assistant Professor of Clinical Urology University of Miami Miller School of Medicine Department of Urology Miami, FL June 2005 à June 2008 Assistant Professor of Clinical Urology Columbia University Department of Urology New York, NY July 2008 à November 2013 Associate Professor of Urology Columbia University Department of Urology New York, NY November 2013 - date Alan M. Nieder, M.D. 5 9. Hospital Appointments: Stony Brook University Hospital Stony Brook, NY September 2004 à May 2005 Jackson Memorial Hospital Miami, FL June 2005 à June 2008 Department of Veterans Affairs Medical Center Miami, FL 2005 à June 2008 Mount Sinai Medical Center Miami Beach, FL 2005 à date Co-Chief, Division of Urology Mount Sinai Medical Center Miami Beach, FL 2013 à date Alan M. Nieder, M.D. 6 10. Honors: 1993: B.A. with Honors, University of Michigan 1997: Fred S. Mandelbaum Award, for excellence in Pathology and Allied Sciences, New York University School of Medicine 1997: Samuel Soifer Memorial Award, for excellence in Urology, New Yor University School of Medicine th 2000: Honorable Mention, 50 Ferdinand C. Valentine Resident Essay Contest, New York Academy of Medicine, Section of Urology 2000: Resident Traveling Scholar, International Volunteers in Urology, Bhopal, India ndrd 2003: 2 Place, 53 Ferdinand C. Valentine Resident Essay Contest, New York Academy of Medicine, Section of Urology 2006: Travel Award, American Urologic Association, Society of Basic Urologic Research, Madison, WI 2007: Honorable Mention, Journal of Urology, bladder cancer manuscript reviews 2008: American Urologic Association/Astellas Best Abstract, Bladder ca ÅProstate Radiotherapy: what is the contemporary risk of bladder rectal carcinoma?Æ Orlando, FL 2008: American Urologic Association Annual Meeting: Best poster during moderated poster session ÅBladder cancer: detection and screenin Orlando, FL 2009: Best Reviewer, Journal of Urology, prostate cancer manuscript reviews 2014: Best Reviewer, Journal of Urology, prostate cancer manuscript reviews 2015: Southeast Section of AUA, Visiting Professor, Florida Urologic Societ Annual Meeting Alan M. Nieder, M.D. 7 11. Fellowship & grant support: N.A. Alan M. Nieder, M.D. 8 12. Departmental & University Committees: University Committees: Member, Graduate Medical Education Committee Stony Brook Medical Center 2004 à 2005 Member, Graduate Medical Education Committee University of Miami/Jackson Memorial Hospital 2005 à June 2008 Member, Cancer Committee University of Miami/Jackson Memorial Hospital 2005 à June 2008 Member, Protocol Review Committee University of Miami/Jackson Memorial Hospital 2005 à 2007 Member, Admissions Committee University of Miami Miller School of Medicine 2006 à June 2008 Non-University Committees: Member, Bellevue House Staff Affairs Committee 2001 à 2003 Member, NYU Medical Center House Staff Council, 20012003 à Co-Chairman, NYU Medical Center House Staff Council 20022003 à Member, Graduate Medical Education Committee Mount Sinai Medical Center 2005 à date Member, Perioperative Resource Committee Mount Sinai Medical Center 2006 à date Alan M. Nieder, M.D. 9 Member, Credentialing Committee Mount Sinai Medical Center 2008 à 2013 Member, Surgical Review Committee Mount Sinai Medical Center 2009 à date Medical Executive Committee Mount Sinai Medical Center 2015 à date Alan M. Nieder, M.D. 10 13. Teaching experience and responsibilities: Urologic Oncology Fellowship Director Mount Sinai Medical Center Department of Urology 2005 à date Residency Program Site Director Mount Sinai Medical Center Department of Urology University of Miami Miller School of Medicine 2005 à June 2008 Co-Assistant Residency Program Director Department of Urology University of Miami Miller School of Medicine 2007 à June 2008 Program Director, Urology Residency Mount Sinai Medical Center 2011 à date Alan M. Nieder, M.D. 11 14. Other professional activities: Editorial Responsibilities: Editorial Board: International Brazilian Journal of Urology, 2006-date Advances in Urology, 2013-2015 Reviewer: Journal of Urology, 2005-date International Brazilian Journal of Urology, 2005-date Cancer Letters, 2005-date Expert Review of Anticancer Therapy, 2006-date Hospital Physician, 2006-date Asian Journal of Andrology, 2006-date International Urogynecology Journal, 2006-date Urologic Oncology: Seminars and Original Investigations, 2006-date Urology, 2007-date European Urology, 2007-date BMC Cancer, 2009-date UroToday International Journal, 2009-date Radiation Oncology, 2011-date World Journal of Urology, 2011-date Clinical Epidemiology, 2012-date International Journal of Urology, 2012-date Urology Practice, 2014-date Alan M. Nieder, M.D. 12 : Other Professional Activities Panelist: Bladder Cancer Guidelines Society of International Urology/World Health Organization 2004 Invited Lecturer nd 2 Annual Maurice Gonder Urology Symposium. SUNY Stony Brook 2005 Panelist: Prostate Cancer Symposium th 16 Annual Challenging Cases in Urology Miami, FL February 2006 Invited Lecturer Jamaican Urologic Association Annual Meeting Kingston, Jamaica February 2009 Invited Lecturer The Grand Bahamas Medical and Dental Association th 9 Annual Scientific Medical Conference Freeport, Bahamas 2009 Panelist: Management of Non-Invasive Bladder Cancer Florida Urological Society, Annual Meeting Naples, FL September 2009 Moderator: Advanced Prostate Cancer American Urologic Association Annual Meeting San Francisco, CA May 2010 Invited Lecturer Jamaican Urologic Association Annual Meeting Kingston, Jamaica February 2011 Abstract Reviewer: Advanced Prostate Cancer American Urologic Association Annual Meeting Atlanta, GA May 2012 Alan M. Nieder, M.D. 13 Invited Lecturer Jamaican Urologic Association Annual Meeting Kingston, Jamaica February 2013 Abstract Reviewer: Advanced Prostate Cancer American Urologic Association Annual Meeting San Diego, CA May 2013 Invited Lecturer Florida Urologic Society Annual Meeting Tampa, FL August 2013 Moderator: Prostate Cancer North Central Section American Urologic Association Annual Meeti Naples, FL October 2013 External Examiner Urology Final Oral Exam University of the West Indies Kingston, Jamaica December 2013 Invited Lecturer Jamaican Urologic Association Annual Meeting Kingston, Jamaica February 2014 Abstract Reviewer: Advanced Prostate Cancer American Urologic Association Annual Meeting Orlando, FL May 2014 Moderator: Prostate Cancer, Detection & Screening American Urologic Association Annual Meeting Orlando, FL May 2014 Invited Lecturer Florida Urologic Society Annual Meeting Miami Beach, FL August 2014 Alan M. Nieder, M.D. 14 Abstract Reviewer: Invasive Bladder Cancer American Urologic Association Annual Meeting New Orleans, LA May 2015 Moderator: Prostate Cancer, Detection & Screening American Urologic Association Annual Meeting New Orleans, LA May 2015 Invited Lecturer Florida International University HWCOM Medical Congress Miami Beach, FL July 2015 Southeast Section of AUA, Visiting Professor Florida Urologic Society Annual Meeting Orlando, FL August 2015 Invited Lecturer Moffitt Cancer Center: New Frontiers in Urologic Oncology Tampa, FL September 2015 Abstract Reviewer: Invasive Bladder Cancer American Urologic Association Annual Meeting San Diego, Ca May 2016 Alan M. Nieder, M.D. 15 15. Publications: Original, Peer Reviewed Articles: 1.Lepor H, , Feser J, OÈConnell C, Dixon C. Effect of Nieder AM terazosin on prostatism in men with normal and abnormal peak urinary flow rates. Urology 49(3): 476-480, 1997. 2.Lepor H, , Feser J, OÈConnell C, Dixon C. Total prostate Nieder AM and transition zone volumes, and transition zone index are poorl correlated with objective measures of clinical benign prostatic hyperplasia. Journal of Urology, 158(1): 85-88, 1997. 3., Chun T, Nitti V. Total vaginal prolapse with multiple Nieder AM vesical calculi after hysterectomy. Journal of Urology, 159(3): 983, 1998. 4.Lepor H, Ferrandino M. Intraoperative and Nieder AM, postoperative complications following radical retropubic prostatectomy in a consecutive series of 1,000 cases. Journal of Urology, 166(5): 1729-1733, 2001. 5., Rosenblum N, Lepor H. Comparison of two different doses Nieder AM of preoperative recombinant erythropoietin in men undergoing radical retropubic prostatectomy. Urology, 57(4): 737-741, 2001. 6.Lepor H, , Fraiman M. Early removal of the urinary Nieder AM catheter following radical retropubic prostatectomy is both feas and desirable. Urology, 58(3): 425-429, 2001. 7.Stifelman M, . Prospective comparison of hand-assisted Nieder AM laparoscopic devices. Urology, 59(5): 668-672, 2002. 8.Stifelman MD, Handler T, , DelPizzo J, Taneja S, Sosa Nieder AM RE, Shichman SJ. Hand-assisted laparoscopy for large renal specimens: a multi-institutional study. Urology, 61(1): 78-82, 2003. 9., Taneja SS, Zeegers M, Ostrer H. Genetic counseling for Nieder AM prostate cancer risk. Clinical Genetics, 63(3): 169-176, 2003. 10. & Taneja SS. The role of partial nephrectomy for renal Nieder AM cell carcinoma in contemporary practice. Urologic Clinics of North America, 30(3): 529-542, 2003. 11.Sved PD, Gomez P, , Manoharan M, Kim S, Soloway Nieder, AM MS. Upper tract tumor following radical cystectomy for transiti Alan M. Nieder, M.D. 16 cell carcinoma of the bladder. British Journal of Urology International, 94(6): 785-789, 2004. 12.Walden PD, Globina Y, Induction of anoikis by Nieder AM. doxazosin in prostate cancer cells is associated with activation caspase-3 and a reduction of focal adhesion kinase. Urology Research, 32(4): 261-265, 2004. 13., Simon MA, Manoharan M, Kim SS, Soloway MS. Nieder AM Intraoperative cell salvage during radical prostatectomy: a safe technique for JehovahÈs Witnesses. International Brazilian Journal of Urology, 30(5): 377-379, 2004. 14.Zeegers MP, Kiemeny L, , Ostrer H. How strong is the Nieder AM association between CAG and GGM repeat length polymorphisms in the androgen receptor gene and prostate cancer risk? Cancer Epidemiology, Biomarkers & Prevention, 13(11): 1765-1711, 2004. 15., Sved PD, Manoharan M, Gomez P, Kim S, Soloway Nieder AM MS. Urethral recurrence following cystoprostatectomy: Implicati for urinary diversion and monitoring. Urology, 64(5): 950-954, 2004. 16., Brausi M, Lamm D, OÈDonnell M, Tomita K, Woo H, Nieder AM Jewett MAS. SIU/ICUD 2004 International Consensus Conference on Bladder Cancer: T1 Report. Urology, 66(Supp 6A): 108-125, 2005. 17., Sved PD, Stein JP, Skinner DG, Soloway MS. Nieder AM Cystoprostatectomy and orthotopic ileal neobladder reconstructio for management of bacille Calmette Guerin-induced bladder contractures. Urology, 65(5): 909-912, 2005. 18.Stifelman MD, Caruso RP, , Taneja SS. Robot-assisted Nieder AM laparoscopic partial nephrectomy. Journal of the Society of Laparoendoscopic Surgeons. 9(1): 83-86, 2005. 19.Sved PD, , Manoharan M, Gomez P, Meinbach DS, Kim Nieder AM SS, Soloway MS. Evaluation of analgesic requirements and postoperative recovery after radical retropubic prostatectomy ut long-acting spinal anesthesia. Urology, 65(3): 509-512, 2005. 20., Manoharan M, Kim SS, Soloway MS. Neither alpha- Nieder AM blocker therapy nor cystography is required prior to early cathe removal after radical prostatectomy. British Journal of Urology International, 95(3): 323-325, 2005. 21.Meinbach D, Manoharan M, Soloway MS. Transurethral Nieder AM, Alan M. Nieder, M.D. 17 bladder tumor resection: Intraoperative and postoperative compli in a residency setting. Journal of Urology, 174(6): 2307-2309, 2005. 22., Carmack AJK, Sved PD, Kim SS, Manoharan M, Nieder AM Soloway MS. Intraoperative cell savage during radical prostatectomy is not associated with a higher rate of biochemical recurrence. Urology, 65(4): 730-734, 2005. 23.Madjar S, Frisher Z, Waltzer W. Bladder wall abscess Nieder AM, following midurethral sling procedure. International Urogynecology Journal, 17(2): 180-181, 2006. 24.Lipke M, Madjar S. Transitional cell carcinoma Nieder AM, associated with marijuana: case report and review of the literat Urology, 67(1): 200.e5-200.e6, 2006. 25., Simon MA, Kim SS, Manoharan M and Soloway MS. Nieder AM Radical cystectomy after BCG for high risk Ta, T1 and CIS: defin the risk of initial bladder preservation. Urology, 67(4): 737-741, 2006. 26. & Soloway MS. Eliminate the term ÅsuperficialÆ bladder Nieder AM cancer. Journal of Urology, 175(2): 417-418, 2006. 27.John S, Messina CR, Granek IA, Adler HL. Are Nieder AM, patients aware of the association between smoking and bladder cancer? Journal of Urology, 176(6): 2405-2408, 2006. 28.Araki M, Manoharan M, Vyas, S, , Soloway MS. A Nieder AM pelvic drain can often be avoided after radical retropubic prostatectomy: An update in 552 cases. European Urology, 50(6): 1241-1247, 2006. 29.Manoharan M, Reyes, M, Vyas, S, , Soloway MS. Nieder AM Concurrent radical retropubic prostatectomy and Lichtenstein inguinal hernia repair through a single modified Pfannenstiel incision: a 3-year experience. British Journal of Urology International, 98(2): 341-344, 2006. 30. & Manoharan M. The role of the surgeon & transurethral Nieder AM resection in the treatment of superficial bladder cancer. The Scientific World Journal Urology, 6: 2626-31, 2006. Alan M. Nieder, M.D. 18 31.Manoharan M, Reyes MA, Singal R, Kava BR, , Soloway Nieder AM MS. Orthotopic ileal neobladder reconstruction for bladder canc adjuvant chemotherapy safe? International Brazilian Journal of Urology, 32(5): 529-535, 2006. 32.Reyes MA, , Kava BR, Soloway MS, Manoharan M. Nieder AM Does body mass index affect outcome after reconstruction of orthotopic neobladder? Urology, 69(3): 475-478, 2007. 33.Manoharan M, Ayyathurai R, , Soloway MS. Nieder AM Hemospermia following transrectal ultrasound-guided prostate biopsy: a prospective study. Prostate Cancer Prostatic Diseases, 10(3): 283-287, 2007. 34.Araki M, , Manoharan M, Yang Y, Soloway MS. Lack Nieder AM of progress in the early diagnosis of bladder cancer. Urology, 69(2): 270-274, 2007. 35., Soloway MS, Herr H. Should we abandon the FISH Test? Nieder AM European Urology, 51(6): 1469-1471, 2007. 36., Manoharan M, Yang Y, Soloway MS. Intraoperative Nieder AM cell savage during radical cystectomy does not affect long-term survival. Urology, 69(5): 881-884, 2007. 37., MacKinnon JA, Lee DJ, Huang Y, Fleming LE, Nieder AM Koniaris LG. Florida bladder cancer trends 1981-2004: Minimal progress in the reduction of advanced disease. Journal of Urology, 179(2): 491-495, 2008. 38.Manoharan M, Ayyathurai R, , Soloway MS. Modified Nieder AM pfannenstiel approach for radical retropubic prostatectomy: a 3-year experience. Prostate Cancer Prostatic Diseases, 11(1): 74-78, 2008. 39. and Soloway MS. ItÈs not a radical prostatectomy, itÈs a Nieder AM total prostatectomy. European Urology, 54(4): 715-716, 2008. 40.Sunkara R, Ayyathurai R, , Manoharan M. Delayed local Nieder AM recurrence following radiation therapy for muscle-invasive bladder cancer emphasizing the need for lifelong surveillance: a case report. The Scientific World Journal Urology, 19(8): 166-8, 2008. 41.Ayyathurai R, Manoharan M,, Kava B, Soloway MS. Nieder AM Factors affecting erectile function after radical retropubic prostatectomy: results from 1620 consecutive patients. British Journal of Urology International, 101(7): 833-6, 2008. Alan M. Nieder, M.D. 19 42.Manoharan M. Ayyathurai R, de Los Santos R, Soloway Nieder AM, MS. Presentation and outcome in Hispanic following radical cystectomy. International Brazilian Journal of Urology, 34(6): 691- 698, 2008. 43., Porter MP, Soloway MS. Radiation therapy for prostate Nieder AM cancer increases subsequent risk of bladder and rectal cancer: a population-based cohort study. Journal of Urology, 180(5): 2005- 2010, 2008. 44.Tunuguntala HS, Manoharan M. Neobladder Nieder AM, reconstruction following radical cystoprostatectomy for invasive bladder cancer. Minerva Urology Nephrology, 61(1); 41-54, 2009. 45., MacKinnon JM, Fleming L, Kearney G, Sherman R, Nieder AM Huang Y, Lee DJ. Bladder cancer clusters in Florida: identifying populations at risk. Journal of Urology, 182(1): 46-51. 2009. 46.Brookfield KF, Cheung MC, Gomez C, Yang R, , Lee Nieder AM DJ, Koniaris LG. Survival disparities among African American women with invasive bladder cancer in Florida. Cancer, 115(18): 4196-4029, 2009. 47., Lotan Y, Nuss GR, Langston JP, Vyas S, Manoharan M, Nieder AM Soloway MS. Are patients with hematuria appropriately referred Urology? A multi-institutional questionnaire based survey. Urologic Oncology, 28(5): 500-503, 2010. 48., Nebhnani J, Bianco F. The optimal diagnosis of Nieder AM urothelial carcinioma of the bladder. Current Cancer Therapy Reviews, 7(4): 267-271, 2011. 49.Delto JC, Wayne GF, Garces S, Medina AM, An adult Nieder AM. case of paratesticular spindle cell rhabdomyosarcoma. Urology Case Reports, 2: 126-128, 2014. 50.Badani KK, Rothberg MB, Bergman A, Silva MA, Shapiro EY, , Patel T, Bhandari A. Robotic-assisted Nieder AM nephroureterectomy and bladder cuff excision without patient or robot repositioning: description of modified port placement and technique. J Laparoendoscopic Adv Surg Tech, 24(9): 647-650, 2014. Alan M. Nieder, M.D. 20 51.Delto JC, Wayne G, Yanes R, Bhandari A. Reducing Nieder AM, robotic prostatectomy costs by minimizing instrumentation. Journal of Endourology, 29(5): 556-560, 2015. 52.Whalen MJ, RiChard JL, Ghandour R, Lipsky M, Piecuch M, Benson MC, , DeCastro GJ, McKiernan JM. Lessons learned Nieder AM from routine intraoperative ureteral margin frozen sections duri radical cystectomy. Urology Practice, in press. 53.nes R, Glamore M, Delto JC, Bhandari A, . Urology Nieder AM patients and the internet: socioeconomic status and language ski significantly impact usage. Urology Practice, in press. Alan M. Nieder, M.D. 21 Chapters 1. & Lepor H. ÅComplications of Pharmacotherapy,Æ in Nieder AM Taneja S, Smith RB, Ehrlich RM (Eds.): Complications of Urologic rd Surgery, 3 edition. W.B. Saunders, pp 69-79, 2001. 2. & Soloway MS. ÅCystoscopy,Æ in Lerner SP, Nieder AM Schoenberg MP, Sternberg CN (Eds.): Textbook of Bladder Cancer. Taylor & Francis, pp 179-186, 2006. 3.Jewett MAS, , Brausi M, Lamm D, OÈDonnell M, Tomita Nieder AM K, Woo H. ÅT1 urothelial carcinoma of the bladder,Æ in Soloway Carmack A, Khoury S (Eds): Bladder Tumors. Health Publication LTD, pp 189-217, 2006. 4.Kava BR, , Soloway MS. ÅTreatment of low risk prostate Nieder AM cancer,Æ in Feneley M & Payne H (Eds): Therapeutic Strategies in Prostate Cancer. Oxford Press, pp 99-114, 2007. 5.Manoharan M & . ÅCystectomy and urinary diversion,Æ in Nieder AM Nargund VH, Ragahavan D, Sandler HM (Eds): Handbook of Urologic Oncology. Springer, 2007. 6., Manoharan M. ÅHigh-grade prostatic intraepithelial Nieder AM neoplasia,Æ in Silva O & Abdel-Wahab M (Eds): Prostate Cancer: A Practical Guide. Elsevier, pp 110-114, 2008. 7.Kava B, Manoharan M, , Soloway M. ÅRadical Nieder AM prostatectomy,Æ in Silva O & Abdel-Wahab M (Eds): Prostate Cancer: A Practical Guide. Elsevier, pp 153-178, 2008. 8. & Soloway MS. ÅFuture directions in nephron sparing Nieder AM surgery,Æ in Soloway MS & Sasidarahan K (Eds): Nephron Sparing Surgery. Informa Healthcare LTD, pp 147-189, 2008. 9. & Soloway MS. ÅPreparation for prostate biopsy,Æ in Nieder AM Jones JS (Ed): Prostate Biopsy: Indications, Techniques and Complications. Humana Press, pp 97-104, 2008. 10.Cooke T & , ÅComplications of Pharmacotherapy,Æ in Nieder AM Taneja S (Ed.): Complications of Urologic Surgery, 4th edition. Saunders Elsevier, pp 85-94, 2010. Alan M. Nieder, M.D. 22 Letters to the Editor: 1., Soloway MS, Jewett MAS. Re: Can restaging transurethral Nieder AM resection of T1 bladder cancer select patients for immediate cystectomy? Journal of Urology, 178(1): 352, 2007. 2., Soloway MS, Herr HReply to Tine Hajdinjak and Nadja Nieder AM. Kokalj-Vokac's Letter to the Editor re: Mecedes Marin-Aguilera, Lourdes Mengual, Maria Jose Ribal et al. Utility of Fluorescence In Situ Hybridization as a Non-invasive Technique in the Diagnosis of Upper Urinary Tract Urothelial Carcinoma. Eur Urol 2007; 51:409-15 and Alan M. Nieder, Mark S. Soloway and Harry W. Herr. Should We Abandon the FISH Test? European Urology, 52(1): 290, 2007. 3. and Lee DJ. Re: The causal role of cigarette smoking in Nieder AM bladder cancer initiation and progression, and the role of urolo smoking cessation. Journal of Urology, 180(6): 2713, 2008. Alan M. Nieder, M.D. 23 Invited Commentary: 1. & Soloway MS. We are not yet ready to abandon Nieder AM cystoscopy. Nature Clinical Practice Urology, 4(3):130-1, 2007. 2.. Regarding: Herr HW & Donat SM. Management of low- Nieder AM grade papillary bladder tumors. Journal of Urology, 178(4): 1205, 2007. 3.. Regarding: Pantuck AJ, Baniel J, Kirkali Z, Klatte T, Nieder AM Zomorodian N, Yossepowitch O, Belldegrun AS. A novel resectosco for transurethral resection of bladder tumors and the prostate. Journal of Urology, 178(6): 2336, 2007. 4.. Regarding: Dhar N, Klein EA, Reuther A, Thalmann GN, Nieder AM Madersbacher S and Studer UE. Outcome of radical cystectomy wit limited or extended pelvic lymph node dissection. Journal of Urology, 179(3): 878, 2008. 5.. Regarding: Singh A, Kinoshita Y, Rovito PM, Landas S, Nieder AM Silberstein J, Nsouli I, Wang CY and Haas GP. Higher than expect association of clinical prostate and bladder cancers. Journal of Urology, 179(5 supplement): S6, 2008. 6.. Regarding: Lund L, Jacobsen J, Norgaard M, Sorensen HT, Nieder AM Borre M, Blot WJ, McLaughlin JK. Prognostic impact of comorbidit on renal cancer, 1995-2006: Danish population-based Study. Journal of Urology, 182(1): 40, 2009. 7.. Regarding: Verhoest G, Avakian R, Bensalah K, Thuret R, Nieder AM Ficcara V, Artibani W, et al. Urinary collecting system invasion is an independent prognostic factor in organ confined renal cell carci Journal of Urology, 182(3): 859, 2009. 8.. Regarding: Fisher MB, Svatek RS, Hegarty PK, Nieder AM McGinniss JE, Hightower C, Grossman HB, et al. Cardiac history and the risk of post-cystectomy cardiac complications. Urology, 74(5): 1089, 2009. 9.. Regarding: Wu WJ, Ke HL, Yang YH, Li CC, Chou YH, Nieder AM Huang CH. Should patients with primary upper urinary tract canc receive prophylactic intravesical chemotherapy after nephroureterectomy? Journal of Urology, 183(1): 61, 2010. 10.. Regarding: Samplaski MK, Hernandez AV, Gill IS and Nieder AM Simmonds MN. C-Index associates with functional outcomes after laparoscopic partial nephrectomy. Journal of Urology, 184(6): 2263, 2010. Alan M. Nieder, M.D. 24 11.. Regarding: Yafi FA, Aprikian AG, Tanguay S, Kassouf W. Nieder AM Reluctance of general practioners to refer gross hematuria patie urology. Canadian Urologic Association Journal, 5(2): 97-102, 2011. 12.. Regarding: Todenhšfer T, Hennenlotter J, KŸhs U, Tews Nieder AM V, Gakis G, Aufderklamm S, Stenzl A, Schwentner C. Influence of urinary tract instrumentation and inflammation of the performanc urine markers for the detection of bladder cancer. Urology, 79(3): 625, 2012. 13. Regarding: Herati AS, Montag S, Andonian S, Shapiro EY, Nieder AM. Akerman M, Kavoussi LR, Richstone L. Audio and visual analysis of urologic laparoscopic and robotic skills: objective criteria for skill evaluation. Urology, 80(6): 1282, 2012. 14. Regarding: Trends in the Utilization of Neoadjuvant Nieder AM. Chemotherapy in Muscle-Invasive Bladder Cancer: Results from the National Cancer Database. Urology, 83(1): 80, 2014. 15. Regarding: Expert witness testimony in urology Nieder AM. malpractice litigation. Urology, 83(4): 708, 2014. Alan M. Nieder, M.D. 25 Invited Review Articles: 1. & Soloway MS. Diagnosing bladder cancer. US Genito- Nieder AM Urinary Disease, 32-33, 2006. 2.. Team approach to prostate cancer. Coping, 23(3): Nieder AM May/June 2009. 3. & Yanes R. Team approach to prostate cancer. Coping, Nieder AM May/June 2013. Alan M. Nieder, M.D. 26 Published Abstracts: 1., Feser J, OÈConnell C, Dixon C, Lepor H. Effect of Nieder AM terazosin on prostatism in men with normal and abnormal peak urinary flow rates. Poster presentation at AUA Annual Meeting, New Orleans LA, April 1997. Abstract #745. 2., Rosenblum N, Lepor H. Relative effectiveness of two Nieder AM different doses of recombinant erythropoietin (rEPO) in men undergoing radical retropubic prostatectomy. Poster presentatio AUA Annual Meeting, Atlanta GA, April 2000. Abstract #1295. 3.Lepor H, Ferrandino M. The intraoperative and Nieder AM, postoperative complications following radical retropubic prostatectomy in a consecutive series of 1,000 cases. Poster presentation at AUA Annual Meeting, Anaheim CA, June 2001. Abstract #1347. 4.Lepor H, , Fraiman M. Early removal of the urinary Nieder AM catheter following radical retropubic prostatectomy is both feas and desirable. Podium presentation at AUA Annual Meeting, Anaheim CA, June 2001. Abstract #618. 5.Walden PD, Globina Y, . Investigation of the non- Nieder AM adrenergic, apoptotic mechanism of action of doxazosin in the prostate. Poster presentation at AUA Annual Meeting, Orlando FL May 2002. Abstract #869. 6., Carmack AJK, Sved PD, Kim SS, Manoharan M, Nieder AM Soloway MS. Intraoperative cell savage during radical prostatec is not associated with a higher rate of biochemical recurrence. Podium presentation at Society of International Urology World Congress, Honolulu HI, October 2004. Abstract #PD-4.11. British Journal of Urology International, 94 (Supp 2): 60, 2004. 7., Sved PD, Manoharan M, Gomez P, Kim SS, Soloway Nieder AM MS. Urethral recurrence following cystoprostatectomy: Implicati for urinary diversion and monitoring. Poster presentation at Society of International Urology World Congress, Honolulu HI, October 2004. Abstract #MP-3.12. British Journal of Urology International, 94 (Supp 2): 16, 2004. 8., Sved PD, Manoharan M, Gomez P, Meinbach DS, Kim Nieder AM SS, Soloway MS. Revised radical retropubic prostatectomy: a challenge to laparoscopic radical prostatectomy? Poster present at Society of International Urology World Congress, Honolulu HI, Alan M. Nieder, M.D. 27 October 2004. Abstract #UP-9.33. British Journal of Urology International, 94 (Supp 2): 221, 2004. 9., Sved PD, Manoharan M, Soloway MS. Modified Nieder AM pfannenstiel incision for radical prostatectomy: a challenge to laparoscopy. Video presentation at Society of International Uro World Congress, Honolulu HI, October 2004. Abstract #V-5.07. British Journal of Urology International, 94 (Supp 2): 161, 2004. 10.Simon M,, Manoharan M, Soloway MS. Radical Nieder AM cystectomy after BCG: are we waiting too long? Podium presentation at AUA Annual Meeting, San Antonio, TX, May 2005. Abstract #1120. 11.Manoharan M, , Vyas S, Soloway MS. Concurrent Nieder AM inguinal hernia repair and radical retropubic prostatectomy thro single modified Pfannenstiel incision: 3 year experience. Poste presentation at AUA Annual Meeting, Atlanta, GA, May 2006. Abstract #94662. Journal of Urology, 175 (Supp 4): 518, 2006. 12.Luongo T, Ayyathurai R, , Manoharan M, Soloway MS. Nieder AM Lymphovascular invasion in bladder cancer: is it an important prognostic indicator? Podium presentation at AUA Annual Meeting, Anaheim, CA, May 2007. Abstract #1665. Journal of Urology, 177 (Supp 4): 552, 2007. 13., Manoharan M, Vyas S, Soloway MS. Evaluation and Nieder AM work-up of hematuria among primary care physicians in Miami-Dade County: an anonymous questionnaire-based survey. Poster presentation at AUA Annual Meeting, Anaheim, CA, May 2007. Abstract #1082. Journal of Urology, 177 (Supp 4): 357, 2007. 14.Manoharan M, Vyas S, Ayyathurai R, , Soloway MS. Nieder AM Radical cystectomy in octogenarians: is routine post-operative intensive care monitoring necessary? Podium presentation at AUA Annual Meeting, Anaheim, CA, May 2007. Abstract #572. Journal of Urology, 177 (Supp 4): 191, 2007. 15.Ayyathurai R, Manoharan M, , Soloway MS. Factors Nieder AM affecting potency following radical retropubic prostatectomy: results from 1620 consecutive patients. Poster presentation at AUA Annu Meeting, Anaheim, CA, May 2007. Abstract #558. Journal of Urology, 177 (Supp 4): 186, 2007. 16.Manoharan M, Reyes MA, , Kava BR, Soloway MS. Nieder AM Does body mass index affect outcome after reconstruction of orthotopic neobladder? Poster presentation at AUA Annual Meeting, Alan M. Nieder, M.D. 28 Anaheim, CA, May 2007. Abstract #191. Journal of Urology, 177 (Supp 4): 64, 2007. 17.Ayyathurai R, Luongo T, , Manoharan M, Soloway MS. Nieder AM Outcomes of pT0 at radical cystectomy without neoadjuvant therap Poster presentation at AUA Annual Meeting, Orlando, FL, May 2008. Abstract #1617, Journal of Urology, 179 (Supp 4): 552, 2008. 18., Porter MP, Soloway MS. Prostate Radiotherapy: What Nieder AM is the contemporary risk of bladder and rectal carcinoma. Poste presentation at AUA Annual Meeting, Orlando, FL, May 2008. Abstract #935, Journal of Urology, 179 (Supp 4): 322, 2008. 19., MacKinnon JA, Huang Y, Fleming LE, Koniaris LG, Nieder AM Lee DJ. Florida state bladder cancer clusters: Identifications of populations at risk. Poster presentation at AUA Annual Meeting, Orlando, FL, May 2008. Abstract #933, Journal of Urology, 179 (Supp 4): 322, 2008. 20. Ruiz A. What do most patients with bladder cancer Nieder AM, ultimately succumb to: A 25-year follow-up of a single institutionÈs bladder cancer registry (1980-2004). Podium presentation at AUA Annual Meeting, San Francisco, CA, May 2010. Abstract #1026. Journal of Urology, 183(supp 4): e399. 21.Neithlich T, Reddy N, , Neithlich J. Reducing radiation Nieder AM exposure with imaging patients with hematuria. Poster presentation at AUA Annual Meeting, Washington D.C., May 2011. Abstract #2217, Journal of Urology, 185 (supp 4), e890. 22.Bergman A, Patel T, Kanagarajah P, , Bhandari A, Nieder AM Badani K. Technique of robotic assisted nephroureterectomy with bladder cuff excision: no patient or robotic positioning necessa Video presentation at AUA Annual Meeting, San Diego, CA, May 2013. Abstract v1271. 23.Hamada A, Santos J, , Bhandari A. Minimizing warm Nieder AM ischemia during robotic assisted partial nephrectomy. Video presentation at AUA Annual Meeting, Orlando, FL, May 2014. 24.Diaz GA, Yanes RE, Bhandari A, . High risk of priapism Nieder AM in recreational intracavernosal drug abusers. Podium presentation at AUA Annual Meeting, New Orleans, LA, May 2015. Abstract PD2- 08. Alan M. Nieder, M.D. 29 Audio-Taped Discussions: 1.. ÅConversations with Urologic Oncology InvestigatorsÆ, in Nieder AM Love N (ed): Prostate Cancer Update, Vol 5, Issue 2, 2006. 2.. Meet the Professors: A case-based discussion on the Nieder AM management of prostate cancer in the localized and metastatic se in Love N (ed): Prostate Cancer Update, Vol 1, Issue 1, 2007. Alan M. Nieder, M.D. 30 Presented Abstracts: 1.Stifelman M, . A prospective comparison of hand-assisted Nieder AM laparoscopic devices. Poster presentation at World Congress of Endourology, Bangkok, Thailand, November 2001. 2.Simon M,, Manoharan M, Soloway MS. Radical cystectomy Nieder AM after BCG: are we waiting too long? Podium presentation at AUA Southeast Section, Charleston, SC, March 2005. 3.Araki, M, Manoharan M, , Soloway MS. Lack of progress: the Nieder AM early diagnosis of bladder cancer. Poster presentation at Societ Urologic Oncology Meeting, Bethesda, MD, December 2005. 4.Cohen B, Manoharan M, Reyes M, , Soloway MS. Orthotopic Nieder AM neobladder reconstruction following cystectomy for bladder cance adjuvant chemotherapy safe? Poster presentation at Society of U Oncology Meeting, Bethesda, MD, December 2005. 5., Ayyathurai R, Manoharan M, Soloway MS. Can bladder Nieder AM wash cytology predict pathologic outcomes at TURBT? Poster presentation at Society of Urologic Oncology Meeting, Bethesda, December 2006. 6., Manoharan M, Vyas S, Soloway MS. Evaluation and work- Nieder AM up of hematuria among primary care physicians in Miami-Dade County: an anonymous questionnaire-based survey. Poster presentation at Southeastern Section American Urologic Association, Orlando, FL, 2007. 7., MacKinnon JA, Lee DJ, Huang Y, Fleming LE, Koniaris Nieder AM LG. Florida bladder cancer trends 1981-2004: a population still at risk. Poster presentation at American Society of Preventative Oncology Houston, TX, March 2007. 8., MacKinnon JA, Lee DJ, Huang Y, Fleming LE, Koniaris Nieder AM LG. Florida bladder cancer trends 1981-2004: Advanced cases continue to plaque a population at risk. Podium presentation at North Ce Section American Urologic Association, Hollywood, FL, October 20 9., MacKinnon JA, Lee DJ, Huang Y, Fleming LE, Koniaris Nieder AM LG. Florida bladder cancer trends 1981-2004: Advanced cases continue to plaque a population at risk. Poster presentation at American Association of Cancer Research: Frontiers in Cancer Prevention R meeting, Philadelphia, PA, December 2007. 10. Ruiz A. What do most patients with bladder cancer Nieder AM, ultimately succumb to: A single institution bladder cancer regis Alan M. Nieder, M.D. 31 25-year follow-up (1980-2004). Podium presentation at Southeastern Section American Urologic Association, Miami Beach, FL, March 2010. 11.Kanagarajah P, Reid G, Bhandari A, Is routine follow-up Nieder AM. ultrasound necessary after ureteroscopy and laser lithotripsy? Podium presentation at Southeastern Section American Urologic Association, Williamsburg, VA, March 2013. 12.Yanes R, Kanagarajah P, Bhandari A, . Can a negative Nieder AM CertNDx urine test obviate the need for further hematuria workup presentation at Southeastern Section American Urologic Association, Williamsburg, VA, March 2013. 13.Kanagarajah P, , Santos J, Bhandari A. Robotic Nieder AM nephroureterectomy without re-docking and re-positioning the robot. Poster presentation at Southeastern Section American Urologic Association, Williamsburg, VA, March 2013. 14.Hamada A, Santos-Cortes J, Bhandari A, . Short-term Nieder AM experience with a modified technique of uretero-ileal anastomosis during radical cystectomy and urinary diversion. Poster presentation at Southeastern Section American Urologic Association, Hollywood, FL, March 2014. 15.Garces S, Delto J, , Medina AM. An adult case of Nieder AM paratesticular spindle cell rhabdomyosarcoma. Poster presentati College of American Pathologists, Chicago, IL, September 2014. 16.Delto J, Sidhu AJ, Wayne G, Yanes R, Bhandari A, . Careful Nieder AM selection of disposables can minimize the cost of ureteroscopy. Poster presentation at Southeastern Section American Urologic Associati Savannah, GA, March 2015. Alan M. Nieder, M.D. 32 Invited Lectures: ÅEvaluation and work-up of hematuria.Æ SUNY Stony Brook, Department of Family Practice, September 2004. ÅTestis carcinoma: diagnosis and treatment.Æ SUNY Stony Brook, Department of Endocrinology, Grand Rounds, March 2005. ÅManagement of superficial bladder cancer.Æ Second Annual Maurice Gonder Urology Symposium: Advances in Adult & Pediatric Urology, SUNY Stony Brook, March 2005. ÅIntroduction to cystoscopy.Æ ACMI Laser Training Course, University of Miami, July 2005. ÅHematuria and bladder cancer.Æ Mount Sinai Medical Center, Department of Medicine, Grand Rounds, September 2005. ÅProstate cancer: diagnosis and treatment.Æ Mount Sinai Medical Center, Department of Medicine, Resident Rounds, December 2005. ÅRenal cell carcinoma: diagnosis, evaluation and treatment.Æ Mou Sinai Medical Center, Department of Medicine, Resident Rounds, January 2006. ÅUrinary retention and catheter placement.Æ Mount Sinai Medical Department of Nursing, June 2006. ÅLower urinary tract symptoms.Æ Mount Sinai Medical Center, Department of Medicine, Resident Rounds, December 2006. ÅRenal cell carcinoma: state of the art.Æ Mount Sinai Medical Center, Department of Medicine, Grand Rounds, April 2007. ÅWhy bladder cancer matters.Æ Mount Sinai Medical Center, Doctors Day, March 2008. ÅUrology for surgeons.Æ Mount Sinai Medical Center, Surgical Grand Rounds, May 2008. ÅFoley Catheterization and Continuous Bladder Irrigation.Æ Mount Center, Department of Nursing, September 2008. ÅBladder Cancer,Æ Jamaican Urologic Association Annual Meeting, Jamaica, February 2009. ÅAdvances in Kidney Cancer,Æ Mount Sinai Medical Center, Department of Medicine, Grand Rounds, September 2009. Alan M. Nieder, M.D. 33 ÅProstate Cancer and Robotic Prostatectomy,Æ The Grand Bahamas M th Dental Association, 9 Annual Scientific Medical Conference, Freeport, Bahamas, October 2009. ÅProstate Cancer, State-of-the-Art,Æ Lower Keys Medical Center, Grand Rounds, Key West, Florida, October 2010. ÅSurgical management of renal cell carcinoma.Æ Jamaican Urologic Annual Meeting, Kingston, Jamaica, February 2011. ÅUrology Basics,Æ Mount Sinai Medical Center, Surgical Grand Rou 2012. ÅPSA screening and prostate cancer,Æ Eleventh Annual Primary Car Symposium, Baptist Health, Marco Island, Florida, June 2012. ÅBladder cancer: How we can improve outcomes.Æ Jamaican Urologic Association Annual Meeting, Kingston, Jamaica, February 2013. ÅHematuria workup: 2013,Æ Florida Urologic Society Annual Meeting, Tampa, FL, August 2013. ÅContemporary surgical management of renal cell carcinoma.Æ Jama Association Annual Meeting, Kingston, Jamaica, February 2014. ÅNegative prostate biopsy.Æ Florida Urologic Society Annual Meeting, Miami Beach, FL, August 2014. ÅRobotic surgery update.Æ Florida International University HWCOM Medical Congress, Miami Beach, FL, July 2015. ÅProstate cancer and testosterone: what is the risk?Æ Florida Ur Annual Meeting, Orlando, FL, September 2015. ÅManagement options for high-grade T1 BCG-refractory bladder cancer.Æ Moffitt Cancer Center: New Frontiers in Urologic Oncology, Tampa, FL, September 2015. ÅFuture of biomarkers for urothelial malignancies.Æ Moffitt Canc Frontiers in Urologic Oncology, Tampa, FL, September 2015. Alan M. Nieder, M.D. 34 Community Lectures: ÅDiagnosis and Treatment of Prostate Cancer.Æ Cuban Synagogue, Miami Beach, Fl, October 2003 . ÅProstate Cancer: Modern Diagnosis and Treatment.Æ American Urol Association Foundation, Prostate Health Conference. Florida Atl University, Boca Raton, FL, November 2005. ÅSexuality & Aging.Æ Mt. Sinai Foundation. Fisher Island, FL, January 2006. ÅShould smokers be screened for bladder cancer?Æ American Urolo Association Foundation, Bladder Cancer Advocacy Network. Florid Atlantic University, Boca Raton, FL, March 2007. ÅThe team approach to prostate cancer.Æ GildaÈs Club, Ft. Lauderdale, FL. September 2007. ÅState-of-the-art diagnosis and management of prostate cancer.Æ Sunny Isles Beach, April 2008. ÅState-of-the-art diagnosis and management of BPH.Æ North Miami Beach, May 2008. ÅProstate cancer.Æ GildaÈs Club, Ft. Lauderdale, FL. November 2008. ÅProstate Cancer: diagnosis and treatment.Æ Aventura Community C Aventura, FL, September 2009. ÅBladder cancer.Æ GildaÈs club, Ft. Lauderdale, FL January 2010. ÅProstate Cancer.Æ Aventura Turnberry Jewish Center. Aventura, FL. January 2010. ÅBladder Cancer: contemporary management.Æ Mount Sinai Medical Young FounderÈs Club. Miami Beach, FL, March 2011. ÅHow to prevent urologic problems.Æ Young Israel, Century Villag Pines, FL, January 2012.